Search results
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 2 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 2 days agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 1 day agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 1 day agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 1 day agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 20 hours agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 2 days agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 2 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...